Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: G MEDPAR

Market Cap 26.44K 22.84K 21.04K 19.7K 36.92K 2.51M 37.49K 248K 96.88K 1.22M 99.23K 97.12K 4.24M P/E Ratio 2023 *
-
P/E Ratio 2024 * -
Enterprise Value 26.44K 22.84K 21.04K 19.7K 36.92K 2.51M 37.49K 248K 96.88K 1.22M 99.23K 97.12K 4.24M EV / Sales 2023 *
-
EV / Sales 2024 * -
Free-Float
-
Yield 2023 *
-
Yield 2024 * -
6 months-50.00%
Current year-50.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0.03
3 years 0
Extreme 0
0.4
5 years 0
Extreme 0
235.9
10 years 0
Extreme 0
235.9
Manager TitleAgeSince
Chief Executive Officer 75 2014-10-02
Director of Finance/CFO 46 2022-07-30
Chief Tech/Sci/R&D Officer 56 2017-11-30
Director TitleAgeSince
Director/Board Member 75 2014-10-02
Chairman 72 2014-08-20
Director/Board Member 76 2017-02-23
Date Insider Type Main position Quantity % Market Cap.
23-03-30
AWM Investment Co., Inc.
SellCompany 737,500 37.5554%
23-03-30
AWM Investment Co., Inc.
OtherCompany 1,437,500 73.2011%

Financials

2023 *2024 *
Net sales 20.4M 17.62M 16.24M 15.2M 28.48M 1.94B 28.92M 192M 74.75M 944M 76.56M 74.93M 3.27B -
Net income -3.6M -3.11M -2.87M -2.68M -5.03M -342M -5.1M -33.83M -13.19M -167M -13.51M -13.22M -577M -
Net Debt - -
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
84
Sector
-
Date Price Change Volume
26-06-09 0.000100 $ 0.00% 2,054
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.000100USD
Average target price
210.00USD
Spread / Average Target
+210,000,110.00%
  1. Stock Market
  2. Stocks
  3. GMVDF Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!